Literature DB >> 24486321

Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.

Todd L Mollan1, Yiping Jia1, Sambuddha Banerjee2, Gang Wu3, R Timothy Kreulen2, Ah-Lim Tsai3, John S Olson4, Alvin L Crumbliss2, Abdu I Alayash5.   

Abstract

Haptoglobin (Hp) is an abundant and conserved plasma glycoprotein, which binds acellular adult hemoglobin (Hb) dimers with high affinity and facilitates their rapid clearance from circulation after hemolysis. Humans possess three main phenotypes of Hp, designated Hp 1-1, Hp 2-1, and Hp 2-2. These variants exhibit diverse structural configurations and have been reported to be functionally nonequivalent. We have investigated the functional and redox properties of Hb-Hp complexes prepared using commercially fractionated Hp and found that all forms exhibit similar behavior. The rate of Hb dimer binding to Hp occurs with bimolecular rate constants of ~0.9 μM(-1) s(-1), irrespective of the type of Hp assayed. Although Hp binding does accelerate the observed rate of HbO2 autoxidation by dissociating Hb tetramers into dimers, the rate observed for these bound dimers is three- to fourfold slower than that of Hb dimers free in solution. Co-incubation of ferric Hb with any form of Hp inhibits heme loss to below detectable levels. Intrinsic redox potentials (E1/2) of the ferric/ferrous pair of each Hb-Hp complex are similar, varying from +54 to +59 mV (vs NHE), and are essentially the same as reported by us previously for Hb-Hp complexes prepared from unfractionated Hp. All Hb-Hp complexes generate similar high amounts of ferryl Hb after exposure to hydrogen peroxide. Electron paramagnetic resonance data indicate that the yields of protein-based radicals during this process are approximately 4 to 5% and are unaffected by the variant of Hp assayed. These data indicate that the Hp fractions examined are equivalent to one another with respect to Hb binding and associated stability and redox properties and that this result should be taken into account in the design of phenotype-specific Hp therapeutics aimed at countering Hb-mediated vascular disease. Published by Elsevier Inc.

Entities:  

Keywords:  EPR; Ferryl; Free radicals; Haptoglobin; Heme loss; Hemoglobin A; Iron(IV) oxo; Protein-based radical; Redox potential; Spectroelectrochemistry; Sulfhemoglobin

Mesh:

Substances:

Year:  2014        PMID: 24486321      PMCID: PMC4104362          DOI: 10.1016/j.freeradbiomed.2014.01.030

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  66 in total

1.  The binding of haemoglobin by plasma proteins (haptoglobins); its bearing on the renal threshold for haemoglobin and the aetiology of haemoglobinuria.

Authors:  A C ALLISON; W A REES
Journal:  Br Med J       Date:  1957-11-16

2.  Hemoglobin-based oxygen carriers: current status and future directions.

Authors:  Toby A Silverman; Richard B Weiskopf
Journal:  Transfusion       Date:  2009-11       Impact factor: 3.157

3.  Structure of the haptoglobin-haemoglobin complex.

Authors:  Christian Brix Folsted Andersen; Morten Torvund-Jensen; Marianne Jensby Nielsen; Cristiano Luis Pinto de Oliveira; Hans-Petter Hersleth; Niels Højmark Andersen; Jan Skov Pedersen; Gregers Rom Andersen; Søren Kragh Moestrup
Journal:  Nature       Date:  2012-08-26       Impact factor: 49.962

4.  Modulating heme redox potential through protein-induced porphyrin distortion.

Authors:  Charles Olea; John Kuriyan; Michael A Marletta
Journal:  J Am Chem Soc       Date:  2010-09-22       Impact factor: 15.419

5.  Biphasic nature in the autoxidation reaction of human oxyhemoglobin.

Authors:  M Tsuruga; K Shikama
Journal:  Biochim Biophys Acta       Date:  1997-01-04

6.  The mechanism of autooxidation of myoglobin.

Authors:  R E Brantley; S J Smerdon; A J Wilkinson; E W Singleton; J S Olson
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

Review 7.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

8.  α-Hemoglobin stabilizing protein (AHSP) markedly decreases the redox potential and reactivity of α-subunits of human HbA with hydrogen peroxide.

Authors:  Todd L Mollan; Sambuddha Banerjee; Gang Wu; Claire J Parker Siburt; Ah-Lim Tsai; John S Olson; Mitchell J Weiss; Alvin L Crumbliss; Abdu I Alayash
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

9.  Covalent structure of human haptoglobin: a serine protease homolog.

Authors:  A Kurosky; D R Barnett; T H Lee; B Touchstone; R E Hay; M S Arnott; B H Bowman; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

Review 10.  Prostaglandin H synthase: resolved and unresolved mechanistic issues.

Authors:  Ah-Lim Tsai; Richard J Kulmacz
Journal:  Arch Biochem Biophys       Date:  2009-09-01       Impact factor: 4.013

View more
  32 in total

1.  Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.

Authors:  Tigist Kassa; M B Strader; Akito Nakagawa; Warren M Zapol; Abdu I Alayash
Journal:  Metallomics       Date:  2017-09-20       Impact factor: 4.526

2.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

3.  The Interplay between Molten Globules and Heme Disassociation Defines Human Hemoglobin Disassembly.

Authors:  Premila P Samuel; Mark A White; William C Ou; David A Case; George N Phillips; John S Olson
Journal:  Biophys J       Date:  2020-02-04       Impact factor: 4.033

4.  Lessons Learned from 50 Years of Hemoglobin Research: Unstirred and Cell-Free Layers, Electrostatics, Baseball Gloves, and Molten Globules.

Authors:  John S Olson
Journal:  Antioxid Redox Signal       Date:  2019-10-17       Impact factor: 8.401

5.  Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.

Authors:  Narendranath Reddy Chintagari; Julia Nguyen; John D Belcher; Gregory M Vercellotti; Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2014-12-22       Impact factor: 3.039

6.  Sickle Cell Hemoglobin in the Ferryl State Promotes βCys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10).

Authors:  Tigist Kassa; Sirsendu Jana; Michael Brad Strader; Fantao Meng; Yiping Jia; Michael T Wilson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

7.  Energetics underlying hemin extraction from human hemoglobin by Staphylococcus aureus.

Authors:  Megan Sjodt; Ramsay Macdonald; Joanna D Marshall; Joseph Clayton; John S Olson; Martin Phillips; David A Gell; Jeff Wereszczynski; Robert T Clubb
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

8.  Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.

Authors:  Andres S Benitez Cardenas; Premila P Samuel; John S Olson
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

9.  Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.

Authors:  Narendranath Reddy Chintagari; Sirsendu Jana; Abdu I Alayash
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

10.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.